|
| MK 3207 hydrochloride Basic information |
Product Name: | MK 3207 hydrochloride | Synonyms: | MK3207 HYDROCHLORIDE;MK 3207 HYDROCHLORIDE;MK-3207;2-((R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide hydrochloride;CS-549;(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide hydrochloride;MK 3207 hydrochloride;MK-3207 HCl salt;MK3207 HCl;6,9-Diazaspiro[4.5]decane-9-acetamide, 8-(3,5-difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-, hydrochloride | CAS: | 957116-20-0 | MF: | C31H30ClF2N5O3 | MW: | 594.06 | EINECS: | 200-258-5 | Product Categories: | Inhibitors | Mol File: | 957116-20-0.mol | |
| MK 3207 hydrochloride Chemical Properties |
storage temp. | Store at -20°C | solubility | Soluble in DMSO |
| MK 3207 hydrochloride Usage And Synthesis |
Biological Activity | MK-3207 HCl is a potent CGRP receptor antagonist with IC50 and Ki of 0.12 nM and 0.022 nM, respectively, with high selectivity for human AM1, AM2, CTR, and AMY3. Phase 2. |
| MK 3207 hydrochloride Preparation Products And Raw materials |
|